Always consult with a qualified healthcare provider before starting, stopping, or changing any medication regimen
The results are strong, consistent, and likely position it as a next step beyond current GLP-1 therapies
That rapid growth is also what eventually drew legal attention from Eli Lilly, which well cover in detail further down
GLP-1 medications naturally lower appetite by influencing: Ghrelin (hunger hormone) Insulin response Glucose regulation Gut-brain communication This combination makes it easier for patients to eat smaller portions, reduce cravings, and maintain steady energy levels
When Ozempic initially launched in 2017, less than a third of new patients were able to get commercial insurance to cover their prescriptions
Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis